Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies.
Authors: Weiss, Evanson, McClenahan, Fagliari, Dunnwiddie, Wells
Journal: American journal of veterinary research
Summary
# Editorial Summary Platelet activation has long been suspected in laminitis pathogenesis, but direct evidence has been limited; this 1998 study investigated whether blocking platelet aggregation could prevent carbohydrate overload-induced laminitis in an experimental model. Researchers induced acute laminitis via corn starch administration in 16 ponies—eight received RPR 110885, a synthetic antagonist of the platelet fibrinogen receptor, whilst eight served as untreated controls—and monitored coagulation parameters, platelet function, and platelet-neutrophil aggregate formation over 32 hours. The protective effect was striking: 75% of untreated ponies developed clinical laminitis compared with zero cases in the treated group, with treatment also significantly reducing the pathological increase in circulating platelet-neutrophil aggregates observed during the disease process. These findings provide experimental evidence that platelet activation is mechanistically central to alimentary laminitis development, not merely a secondary phenomenon. For practitioners, whilst this work predates modern antiplatelet therapeutics, it suggests that pharmacological platelet inhibition warrants investigation as a preventative strategy in high-risk situations (such as grain engorgement), potentially offering a rational basis for re-evaluating existing anticoagulant or antiplatelet protocols during acute laminitis management.
Read the full abstract on PubMed
Practical Takeaways
- •Platelet aggregation inhibitors may offer a preventive or therapeutic option for carbohydrate-induced laminitis cases, potentially changing emergency management protocols
- •Managing feed quality and intake to prevent carbohydrate overload remains critical, but pharmacological platelet inhibition shows promise as adjunctive therapy
- •Further clinical trials are needed before this approach can be implemented in field practice, but the mechanism suggests it could benefit high-risk ponies receiving grain or inadvertent carbohydrate exposure
Key Findings
- •6 of 8 untreated ponies developed laminitis after carbohydrate overload, whereas 0 of 8 ponies treated with RPR 110885 platelet aggregation inhibitor developed laminitis
- •RPR 110885 treatment attenuated the increase in platelet-neutrophil aggregates observed in untreated ponies
- •Platelet aggregation is mechanistically involved in the pathogenesis of equine alimentary laminitis